相关实验视频

Updated: Jul 11, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

CAR-T细胞疗法:我们现在处于何处,我们正走向何方?

Jia-Yi Wang¹, Liang Wang¹

¹Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.

Blood science (Baltimore, Md.)

|November 9, 2023

概括

化学抗原受体 (CAR) -T细胞疗法在血液癌症中取得了成功,但面临着挑战. 研究旨在提高CAR-T细胞的安全性和有效性,以减少有毒反应和复发.

科学领域:

免疫治疗是一种免疫疗法.
细胞疗法细胞疗法
在瘤学瘤学.

背景情况:

化学抗原受体 (CAR) -T细胞疗法已被批准用于血液恶性瘤.
卡-T细胞表现出超出血液癌症的潜力,包括固体瘤和自身免疫性疾病.

研究的目的:

为提供当前CAR-T细胞治疗的全面概述.
讨论CAR-T细胞研究中的成就,挑战和未来方向.

主要方法:

关于CAR-T细胞治疗进展的文献综述.
分析当前的挑战和正在进行的研究工作.

主要成果:

目前有九种CAR-T细胞产品可用于治疗血液癌症.
卡特-T细胞在治疗固体瘤,心肌纤维化和自身免疫性疾病方面表现有前途.

结论:

CAR-T细胞疗法在血液性恶性瘤中取得了显著的成功.
解决毒性反应和复发对于推进CAR-T细胞治疗至关重要.
未来的研究重点是提高安全性,有效性和降低复发率.

关键词:

化学抗原受体T细胞治疗细胞因子释放综合征细胞因子释放综合征有效性有效性.血液学血液学血液学

更多相关视频

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...